| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3584903efe1babebbd056e855a2cc2b3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-906
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-65 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-906
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-484 |
| filingDate |
2016-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_875eea8b5b3cde5dcdd2a435cc66b0ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1d70b3d0085a4d1dc7095aa5c826fc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_540b4721c85675158205255454701e0c |
| publicationDate |
2018-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101860119-B1 |
| titleOfInvention |
A composition for preventing or treating calorectal cancer comprising Geijigajakyak Decoction |
| abstract |
The present invention relates to a composition for the prevention or treatment of colorectal cancer, including Geijigajakyak Decoction (GJD), wherein the GJD of the present invention inhibits the motility of human CRC cells and inhibits tumor formation in a mouse model . In addition, GJD inhibits p-JNK and p-p38 MAPK cell signaling pathways that are involved in invasion regardless of cell viability. Thus, the GJD of the present invention may be a powerful adjuvant chemotherapeutic regimen for CRC, and the composition comprising GJD may be useful as a medicament and / or functional food for the improvement, prevention and / or treatment of colorectal cancer. |
| priorityDate |
2016-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |